By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Remedy Pharmaceuticals, Inc. 

802 6th Avenue
Suite 63
New York  New York  10001  U.S.A.
Phone: n/a Fax: n/a



Company News
Biogen (BIIB) Strikes $120 Million+ Deal For Remedy Pharma's Stroke Candidate 5/15/2017 6:04:51 AM
Remedy Pharmaceuticals, Inc. Release: CIRARA Granted Orphan Drug Designation For Treatment Of Severe Cerebral Edema Caused By Acute Ischemic Stroke 1/17/2017 9:02:04 AM
David Epstein Joins As Special Advisor To Remedy Pharmaceuticals, Inc. 11/30/2016 11:12:26 AM
Remedy Pharmaceuticals, Inc.’ Edema And Neuro-Inflammation Advisory Board Provides Guidance On Opportunities In CNS Conditions 8/18/2016 11:14:03 AM
Remedy Pharmaceuticals, Inc. Issues Second Quarter 2016 Report 7/6/2016 10:06:25 AM
Roger Ulrich Joins Board Of Remedy Pharmaceuticals, Inc. 6/21/2016 10:33:19 AM
Remedy Pharmaceuticals, Inc. Receives FDA Fast Track Designation For CIRARA 6/8/2016 12:44:22 PM
Remedy Pharmaceuticals, Inc. Announces Contest To Name Its Subarachnoid Hemorrhage Clinical Trial 6/7/2016 11:22:45 AM
Remedy Pharmaceuticals, Inc. Announces Two Oral Presentations On Results Of CNS-Related Edema Trial At Annual American Academy of Neurology Meeting 4/12/2016 10:12:34 AM
Remedy Pharmaceuticals, Inc. Issues First Quarter 2016 Report 4/6/2016 9:46:57 AM